Aeglea BioTherapeutics, Inc.·4

Mar 1, 5:09 PM ET

Schuchart Aaron 4

4 · Aeglea BioTherapeutics, Inc. · Filed Mar 1, 2019

Insider Transaction Report

Form 4
Period: 2019-02-28
Schuchart Aaron
Chief Business Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2019-02-28+60,00060,000 total
    Exercise: $8.36Exp: 2029-02-27Common Stock (60,000 underlying)
Footnotes (1)
  • [F1]The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 28, 2019, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4